文献速递肿瘤 PET/CT

FDG PET/CT在宫颈神经内分泌癌中的预后价值

Prognostic Value of FDG PET/CT in Patients With Neuroendocrine Carcinoma of the Uterine Cervix.
PubMed 文献 · Clin Nucl Med · 2021-01-01

该回顾性研究纳入22例治疗前接受FDG PET/CT的宫颈神经内分泌癌患者,测量原发灶SUVmax、MTV和TLG。单因素分析显示MTV、TLG和FIGO分期与PFS显著相关,多因素分析中MTV和TLG为PFS独立预后因素;TLG>154.3与OS显著相关。

要点

  • MTV和TLG是宫颈神经内分泌癌PFS的独立预后因素
  • MTV>31.9 cm3、TLG>154.3患者PFS显著更短
  • TLG>154.3是OS的显著预测因素

核心结论

  • FDG PET/CT测量的MTV和TLG是宫颈神经内分泌癌患者PFS的显著预后因素,高MTV和高TLG提示更差临床结局,TLG还可能预测OS。

研究设计与样本

  • 回顾性纳入22例治疗前接受FDG PET/CT的宫颈神经内分泌癌患者,测量原发灶SUVmax、MTV和TLG,采用Kaplan-Meier法、log-rank检验及单因素和多因素Cox比例风险模型分析预后因素与PFS和OS的关系。

主要发现

  • 22例中12例出现疾病进展,5例死亡。
  • 单因素分析显示MTV、TLG和FIGO分期与PFS显著相关(均P<0.05),SUVmax与PFS无显著相关。
  • Kaplan-Meier曲线显示MTV>31.9 cm3(log-rank P<0.001)、TLG>154.3(log-rank P<0.001)和更高FIGO分期(log-rank P=0.026)患者PFS显著更短。
  • 多因素分析中MTV(P=0.017;HR 7.298;95%CI 1.427-37.316)和TLG(P=0.003;HR 15.175;95%CI 2.470-93.244)为独立预后因素。
  • OS单因素分析仅TLG>154.3有统计学意义(P=0.043;HR 9.821;95%CI 1.080-89.290)。

临床怎么用

  • 治疗前FDG PET/CT测得的MTV和TLG可用于宫颈神经内分泌癌风险分层,高MTV或高TLG提示PFS更差,TLG升高还提示OS更差。

局限性

  • 回顾性研究,样本量仅22例。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We evaluated the prognostic value of metabolic parameters measured on pretreatment FDG PET/CT in patients with cervical neuroendocrine carcinomas (NECs). METHODS: A total of 22 patients with cervical NECs who underwent pretreatment FDG PET/CT were retrospectively reviewed. The SUVmax, metabolic tumor volume (MTV), and total lesion glycolysis (TLG) of the primary lesion were measured. The associations between prognostic factors and progression-free survival (PFS) and overall survival (OS) were investigated using the Kaplan-Meier method, log-rank test, and univariate and multivariate Cox proportional hazards model. RESULTS: Of the 22 patients, 12 developed disease progression, and 5 died during the follow-up period. Univariate analyses revealed that MTV, TLG, and the International Federation of Gynecology and Obstetrics stage were significantly associated with PFS (all P < 0.05), whereas SUVmax did not show a significant correlation with PFS. Kaplan-Meier survival curves revealed that patients with MTV >31.9 cm3 (log-rank, P < 0.001), TLG >154.3 (log-rank, P < 0.001), and higher International Federation of Gynecology and Obstetrics stage (log-rank, P = 0.026) had significantly shorter PFS. In the multivariate analyses, MTV (P = 0.017; hazard ratio [HR], 7.298; 95% confidence interval [CI], 1.427-37.316) and TLG (P = 0.003; HR, 15.175; 95% CI, 2.470-93.244) were independent prognostic factors, whereas for OS, the univariate analysis revealed that only TLG >154.3 showed statistical significance (P = 0.043; HR, 9.821; 95% CI, 1.080-89.290). CONCLUSIONS: Metabolic tumor volume and TLG on FDG PET/CT were the significant prognostic factors of PFS in patients with cervical NECs. Patients with high MTV and TLG had worse clinical outcomes. In addition, TLG may also be a predictor of OS.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Jiang Y, Hou G, Li F, et al. Prognostic Value of FDG PET/CT in Patients With Neuroendocrine Carcinoma of the Uterine Cervix. Clin Nucl Med. 2021. PMID: 34619703. doi:10.1097/RLU.0000000000003909

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。